Article
SOX9 is a dose-dependent metastatic fate determinant in melanoma
14 Jan 2019
Abstract excerpt
BACKGROUND: In this research, we aimed to resolve contradictory results whether SOX9 plays a positive or negative role in melanoma progression and determine whether SOX9 and its closely related member SOX10 share the same or distinct targets in mediating their functions in melanoma. METHODS: Immunofluorescence, TCGA database and qPCR were used to analyze the correlation between the expression patterns and levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
